Murai H - Search Results

1

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.

Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. Ikeda S, et al. Among authors: murai h. EMBO J. 1998 Mar 2;17(5):1371-84. doi: 10.1093/emboj/17.5.1371. EMBO J. 1998. PMID: 9482734 Free PMC article.

2

Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation.

Murai H, Okazaki M, Kikuchi A. Murai H, et al. FEBS Lett. 1996 Aug 26;392(2):153-60. doi: 10.1016/0014-5793(96)00806-x. FEBS Lett. 1996. PMID: 8772194 Free article.

3

Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.

Okazaki M, Kishida S, Murai H, Hinoi T, Kikuchi A. Okazaki M, et al. Among authors: murai h. Cancer Res. 1996 May 15;56(10):2387-92. Cancer Res. 1996. PMID: 8625316

4

Characterization of Ral GDP dissociation stimulator-like (RGL) activities to regulate c-fos promoter and the GDP/GTP exchange of Ral.

Murai H, Ikeda M, Kishida S, Ishida O, Okazaki-Kishida M, Matsuura Y, Kikuchi A. Murai H, et al. J Biol Chem. 1997 Apr 18;272(16):10483-90. doi: 10.1074/jbc.272.16.10483. J Biol Chem. 1997. PMID: 9099691 Free article.

5

A new type of mitogenic factor produced by Streptococcus pyogenes.

Yutsudo T, Murai H, Gonzalez J, Takao T, Shimonishi Y, Takeda Y, Igarashi H, Hinuma Y. Yutsudo T, et al. Among authors: murai h. FEBS Lett. 1992 Aug 10;308(1):30-4. doi: 10.1016/0014-5793(92)81043-l. FEBS Lett. 1992. PMID: 1644200 Free article.

6

SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.

Masuda T, Hattori N, Senoo T, Akita S, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Kohno N. Masuda T, et al. Among authors: murai h. Mol Cancer Ther. 2013 Nov;12(11):2378-88. doi: 10.1158/1535-7163.MCT-13-0041. Epub 2013 Aug 29. Mol Cancer Ther. 2013. PMID: 23990114

7

Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer.

Fujitaka K, Hattori N, Senoo T, Iwamoto H, Ohshimo S, Kanehara M, Ishikawa N, Haruta Y, Murai H, Kohno N. Fujitaka K, et al. Among authors: murai h. Oncol Lett. 2011 Jan;2(1):167-170. doi: 10.3892/ol.2010.218. Epub 2010 Nov 23. Oncol Lett. 2011. PMID: 22870147 Free PMC article.

8

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.

Masuda T, Hattori N, Hamada A, Iwamoto H, Ohshimo S, Kanehara M, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Kohno N. Masuda T, et al. Among authors: murai h. Cancer Chemother Pharmacol. 2011 Jun;67(6):1465-9. doi: 10.1007/s00280-011-1555-6. Epub 2011 Jan 28. Cancer Chemother Pharmacol. 2011. PMID: 21274533

9

KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome.

Kondo T, Hattori N, Ishikawa N, Murai H, Haruta Y, Hirohashi N, Tanigawa K, Kohno N. Kondo T, et al. Among authors: murai h. Respir Res. 2011 Mar 22;12(1):32. doi: 10.1186/1465-9921-12-32. Respir Res. 2011. PMID: 21418654 Free PMC article.

10

Four cases of chylous fistula after breast cancer resection.

Nakajima E, Iwata H, Iwase T, Murai H, Mizutani M, Miura S, Kato H. Nakajima E, et al. Among authors: murai h. Breast Cancer Res Treat. 2004 Jan;83(1):11-4. doi: 10.1023/B:BREA.0000010675.87358.b6. Breast Cancer Res Treat. 2004. PMID: 14997050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

550 results

Search Page

Filters